Mark Hamilton

3.3k total citations · 1 hit paper
26 papers, 560 citations indexed

About

Mark Hamilton is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark Hamilton has authored 26 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark Hamilton's work include CAR-T cell therapy research (7 papers), Multiple Myeloma Research and Treatments (4 papers) and Chemokine receptors and signaling (4 papers). Mark Hamilton is often cited by papers focused on CAR-T cell therapy research (7 papers), Multiple Myeloma Research and Treatments (4 papers) and Chemokine receptors and signaling (4 papers). Mark Hamilton collaborates with scholars based in United States, United Kingdom and Taiwan. Mark Hamilton's co-authors include Alan Wolfman, Philipp E. Scherer, Katherine Luby‐Phelps, Nils Halberg, Zhao V. Wang, Jayoung Kim, Todd Schraw, Allan Templeton, Streamson C. Chua and Dorothy I. Mundy and has published in prestigious journals such as New England Journal of Medicine, Blood and Cancer Research.

In The Last Decade

Mark Hamilton

21 papers receiving 546 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy

2024 93 citations Mark Hamilton, Takeshi Sugio et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Hamilton United States	9	194	179	147	113	66	26	560
Evi Debruyne Belgium	6	156 0.8×	148 0.8×	92 0.6×	186 1.6×	17 0.3×	7	653
Lindsay Alpert United States	13	139 0.7×	115 0.6×	184 1.3×	37 0.3×	15 0.2×	47	578
Marı́a Cristina Morán-Moguel Mexico	14	216 1.1×	97 0.5×	93 0.6×	40 0.4×	12 0.2×	42	567
Lyuba Levine United States	12	116 0.6×	132 0.7×	151 1.0×	25 0.2×	32 0.5×	14	388
Leonardo M. Porchia Mexico	10	160 0.8×	43 0.2×	101 0.7×	55 0.5×	53 0.8×	46	411
Garry J. Douglas United States	14	146 0.8×	38 0.2×	133 0.9×	128 1.1×	49 0.7×	34	548
Christine K. Kissel Switzerland	14	242 1.2×	38 0.2×	75 0.5×	82 0.7×	66 1.0×	21	636
Jae Kim South Korea	14	232 1.2×	125 0.7×	151 1.0×	113 1.0×	6 0.1×	24	648
Rosekeila Simões Nomelini Brazil	14	95 0.5×	63 0.4×	235 1.6×	60 0.5×	250 3.8×	67	653
David L. Young United States	11	216 1.1×	98 0.5×	58 0.4×	67 0.6×	34 0.5×	13	591

Countries citing papers authored by Mark Hamilton

Since Specialization

Citations

This map shows the geographic impact of Mark Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hamilton more than expected).

Fields of papers citing papers by Mark Hamilton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hamilton. The network helps show where Mark Hamilton may publish in the future.

Co-authorship network of co-authors of Mark Hamilton

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hamilton. A scholar is included among the top collaborators of Mark Hamilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hamilton. Mark Hamilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yiyun, Zachary Ehlinger, Kun Song, et al.. (2025). Abstract 7123: Unravelling temporal dynamics of GD2-CAR T cell therapy in H3K27M-mutant diffuse midline glioma through comprehensive single-cell and multi-omic profiling. Cancer Research. 85(8_Supplement_1). 7123–7123.

Kramer, Anne Marijn, Yiyun Chen, Hrishikesh K. Srinagesh, et al.. (2024). CD22-Directed CAR T Cell Single Cell Multiomic Features Associated with Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS). Blood. 144(Supplement 1). 911–911.

Hamilton, Mark, Takeshi Sugio, Troy Noordenbos, et al.. (2024). Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. New England Journal of Medicine. 390(22). 2047–2060. 93 indexed citations breakdown →

Goyal, Anmol, Dasom Lee, Eric S. H. Lau, et al.. (2023). Impact of Obesity on Efficacy, Safety, and Expansion Kinetics of Chimeric Antigen Receptor-T (CAR T) Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma (LBCL). Blood. 142(Supplement 1). 3783–3783.

Barrozo, Enrico R., Maxim D. Seferovic, Mark Hamilton, et al.. (2023). Zika virus co-opts microRNA networks to persist in placental niches detected by spatial transcriptomics. American Journal of Obstetrics and Gynecology. 230(2). 251.e1–251.e17. 6 indexed citations

Hamilton, Mark & David B. Miklos. (2023). Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma. Hematology/Oncology Clinics of North America. 37(6). 1053–1075. 1 indexed citations

Su, Yi‐Jiun, Mark Hamilton, Neha Agarwal, et al.. (2023). Post-CAR-T Minimal Residual Disease (MRD) Monitoring in Mantle Cell Lymphoma Enables Early Relapse Detection. Blood. 142(Supplement 1). 1673–1673. 1 indexed citations

Jayasinghe, Reyka G., Mark Hamilton, Sacha Gnjatic, et al.. (2022). Myeloma Developing Regimens Using Genomics (MyDRUG): Longitudinal Single-Cell Transcriptional Landscape of the Myeloma and Immune Microenvironment in Relapsed/Refractory Multiple Myeloma Patients Treated with MEK-Inhibitor, Cobimetinib. Blood. 140(Supplement 1). 7090–7091. 1 indexed citations

Zyromski, Brett, et al.. (2022). Applying an Advocating Student-Environment Lens to Foster Protective Factors: School Counselors’ Role in Buffering ACEs. 8(1). 1–15. 6 indexed citations

10.

Pilcher, William, Beena Thomas, Swati S. Bhasin, et al.. (2021). Characterization of T-Cell Exhaustion in Rapid Progressing Multiple Myeloma Using Cross Center Scrna-Seq Study. Blood. 138(Supplement 1). 401–401. 5 indexed citations

11.

Yao, Lijun, Reyka G. Jayasinghe, Beena Thomas, et al.. (2020). Integrated Cytof, Scrna-Seq and Cite-Seq Analysis of Bone Marrow Immune Microenvironment in the Mmrf Commpass Study. Blood. 136(Supplement 1). 28–29. 8 indexed citations

12.

Khan, Tayeba, Mark Hamilton, Dorothy I. Mundy, Streamson C. Chua, & Philipp E. Scherer. (2009). Impact of Simvastatin on Adipose Tissue: Pleiotropic Effects in Vivo. Endocrinology. 150(12). 5262–5272. 48 indexed citations

13.

Hamilton, Mark. (2007). Multiple births in the United Kingdom – a consensus statement. Human Fertility. 10(2). 71–74. 2 indexed citations

14.

Hamilton, Mark. (2003). Developing clinical standards and accrediting clinics in infertility care. Human Fertility. 6(sup2). S30–S32. 2 indexed citations

15.

Agarwal, Munna L., Chilakamarti V. Ramana, Mark Hamilton, et al.. (2001). Regulation of p53 expression by the RAS-MAP kinase pathway. Oncogene. 20(20). 2527–2536. 43 indexed citations

16.

Hamilton, Mark, et al.. (2001). Randomized controlled trial comparing couple satisfaction with appointment and telephone follow-up consultation after unsuccessful IVF/ICSI treatment. Human Fertility. 4(4). 249–255. 11 indexed citations

17.

Nugent, David, et al.. (2000). BFS recommendations for good practice on the storage of ovarian and prepubertal testicular tissue. Human Fertility. 3(1). 5–8. 7 indexed citations

18.

Hamilton, Mark & Alan Wolfman. (1998). Ha-ras and N-ras regulate MAPK activity by distinct mechanisms in vivo. Oncogene. 16(11). 1417–1428. 66 indexed citations

19.

Hamilton, Mark, et al.. (1995). Ethics and Society: Current attitudes towards egg donation among men and women. Human Reproduction. 10(6). 1543–1548. 45 indexed citations

20.

Acharya, Umesh, D. Stewart Irvine, Mark Hamilton, & Allan Templeton. (1993). The effect of three anti-oestrogen drugs on cervical mucus quality and in-vitro sperm—cervical mucus interaction in ovulatory women. Human Reproduction. 8(3). 437–441. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact